InMode (STU:154) Total Operating Expense: €182.0 Mil (TTM As of Mar. 2026)


STU:154 InMode Ltd STU:154
81 GF Score
Price €12.63
GF Value €17.07
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is InMode Total Operating Expense?

InMode STU:154 -0.63% 81 Total Operating Expense is €182.0 Mil as of Mar. 2026. GuruFocus rates STU:154 with a GF Score™ of 81/100 and a GF Value™ of €17.07 (Modestly Undervalued). The stock has 4 warning signs investors should review.

InMode's Total Operating Expense for the three months ended in Mar. 2026 was €44.5 Mil. InMode's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was €182.0 Mil.

InMode Total Operating Expense Related Terms

InMode Total Operating Expense Historical Data

* Premium members only.

The historical data trend for InMode's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

InMode Total Operating Expense Chart

InMode Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only 120.80 172.69 197.78 195.33 175.57

InMode Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 41.90 46.44 43.80 47.23 44.54
STU:154
81GF Score
InMode Ltd STU:154
Total Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

InMode Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €182.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of €182.0 Mil mean?
InMode (STU:154) has a Total Operating Expense of €182.0 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on InMode and its competitors.
Is InMode's Total Operating Expense too high?
InMode's current Total Operating Expense is €182.0 Mil. Overall, InMode has a GF Score™ of 81/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does InMode's Total Operating Expense compare to SIBN and CBLL?
InMode's Total Operating Expense of €182.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Medical Devices & Instruments company?
A good Total Operating Expense depends on the Medical Devices & Instruments industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on InMode and its competitors. InMode's current Total Operating Expense is €182.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is InMode stock overvalued right now?
Based on GuruFocus' analysis, InMode (STU:154) is currently considered Modestly Undervalued. The stock's GF Value™ is €17.07, compared to a current price of €12.63 — trading 26% below its estimated fair value. The current Total Operating Expense is €182.0 Mil. InMode's overall GF Score™ is 81/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For InMode (STU:154), the current Total Operating Expense is €182.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is InMode (STU:154) Overvalued in 2026?

Based on GuruFocus' analysis, InMode stock appears to be undervalued. The current stock price of €12.63 is trading 26% below its estimated GF Value™ of €17.07. GuruFocus considers InMode to be Modestly Undervalued.

Key valuation signals for STU:154:

  • Total Operating Expense: €182.0 Mil
  • GF Value™: €17.07 vs. price of €12.63 (26% below fair value)
  • GF Score™: 81/100 with 4 warning signs

No single metric tells the full story. See the STU:154 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

InMode Business Description

Other Exchanges INMD:USA
Address Sha’ar Yokneam, Tavor Building, P.O. Box 533, Yokneam, ISR, 2069206
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF, and Morpheus8, among others. Geographically, the company generates the majority of its revenue from the United States, followed by Europe, Asia, Israel, and other regions.
81GF Score

Get the complete analysis for STU:154

Total Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€12.63
Price
€17.07
GF Value